Accelerate Drug Discovery & Development

Drug discovery and development are becoming more challenging. The cost of drug discovery, screening, validation and process development is increasing at a rapid rate while regulatory and quality validations are becoming more stringent. A majority of drug candidates fail before even reaching clinical trial, leaving patients in need without a treatment or hope.

Drug discovery and development doesn't have to be this way. At the Life Sciences companies of Danaher, we see a way to improve drug candidate success rates by 25%, collaborating to help pioneer more effective treatments and architect more efficient solutions that bring the power of science to life.